Ondansetron (zofran) QT prolonging warning

The FDA has issued an advisory to prescribers of the risk of QT prolongation with ondansetron. It should be avoided in patients with prolonged QT, and used cautiously in patients on other QT prolonging drugs (abstract)

Danielle Scheurer

Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.

Leave a Comment